Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
25.09. | WuXi Biologics Introduces TrueSite TI Cell Line Platform | ||
25.09. | Gilead Commits Over $6.5M Toward STEM Education in San Francisco Bay | ||
24.09. | Fujifilm Opens New Manufacturing Site in Holly Springs, NC | ||
24.09. | Ritedose Corp. to Invest $17 Million in Laboratory Expansion | ||
24.09. | Hovione, Microinnova Partner to Test Modular Manufacturing Equipment | ||
24.09. | Kashiv BioSciences & JAMP Pharma Launch Biosimilars in Canada | ||
24.09. | Lilly to Build $6.5B Manufacturing Facility in Houston, Texas | ||
23.09. | Arkivum and PHARMASEAL Partner to Streamline Clinical Trial Data Archiving | ||
23.09. | RION Partners with Lonza for Scalable Exosome-Based Drug Manufacturing | ||
23.09. | Eutecma Appoints Kevin Grogan as Chief Executive Officer | ||
23.09. | eXmoor, Siam Bioscience Partner to Establish CGT Services in Southeast Asia | ||
22.09. | Merck & Co.'s KEYTRUDA QLEX Approved by the FDA | ||
22.09. | Pharma Tech Industries Adds Industry Vet to Executive Team | ||
22.09. | Bristol Myers Squibb Commits to Veeva Vault CRM | ||
22.09. | Enzene Announces Commercial Supply of Pertuzumab | ||
22.09. | Evonik Launches MaxiPure Polysorbate 80 | ||
22.09. | Pfizer to Acquire Metsera Inc. for $4.9 Billion | ||
22.09. | Incyte Appointments Dave Gardner, EVP & Chief Strategy Officer | ||
22.09. | The Groninger Group Acquires Reinraumtechnik Ulm (RTU) | ||
18.09. | Roche to Acquire 89bio and Phase 3 MASH Candidate in Potential $3.5B Deal | ||
18.09. | Kindeva Opens New UK HQ and Manufacturing Site | ||
17.09. | Cellares Selects Technology Providers to Expand Cell Q's Capabilities | ||
17.09. | Wheeler Bio to Support MindImmune's Alzheimer's Prevention Program | ||
17.09. | Mabwell Bioscience, Aditum Bio Form Kalexo Bio | ||
17.09. | GSK to Invest $30B in R&D and Manufacturing in the U.S. |